Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10101308 | The American Journal of Surgery | 2005 | 5 Pages |
Abstract
TIMP-1 manipulation, particularly underexpression, greatly reduces the invasive potential of pancreatic cancer by limiting MMP-2 activity without affecting in vitro cell growth. TIMP-1 is a reasonable molecular target in pancreatic cancer therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Mark M.D., Alexis M.D., Emmanuel M.D., Alexander S. M.D.,